Evaluation of satisfaction and preference in patients with osteoporosis receiving Denosumab
<b>Objective:</b> Satisfaction and preference properties differs in osteoporosis treatment agents. In our study we aimed to evaluate these properties in&n...
Main Author: | Betül Sargın |
---|---|
Format: | Article |
Language: | English |
Published: |
National Scientific Medical Research Center
2021-01-01
|
Series: | Ķazaķstannyṇ Klinikalyķ Medicinasy |
Subjects: | |
Online Access: | https://www.clinmedkaz.org/download/evaluation-of-satisfaction-and-preference-in-patients-with-osteoporosis-receiving-denosumab-9654.pdf |
Similar Items
-
Update on Denosumab Treatment in Postmenopausal Women with Osteoporosis
by: Yong-Ki Min
Published: (2015-03-01) -
Osteoporosis in men: epidemiology and treatment with denosumab
by: Sidlauskas KM, et al.
Published: (2014-04-01) -
Denosumab for the treatment of HIV-associated osteoporosis with fractures in a premenopausal woman
by: E. Marasco, et al.
Published: (2021-04-01) -
Denosumab is the first gene engineered agent for the treatment of osteoporosis
by: O A Nikitinskaya, et al.
Published: (2012-09-01) -
Denosumab treatment in patients with different courses of osteoporosis
by: Liudmila Ya. Rozhinskaya, et al.
Published: (2017-12-01)